PACS Group, Inc. (NYSE: PACS) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $7.7B. The Maz Rating grades it against the other companies in its sector.
PACS Group, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $48.55, PACS Group, Inc. trades at 27.8x trailing earnings, 1.4x sales and 6.3x book value, with an EV/EBITDA of 22.2. Over the last twelve months it generated about $5.7B of revenue and $278M of net income. It runs a gross margin of 15.7%, an operating margin of 7.4% and a net margin of 4.9%. It shows return on equity of 25.8%, return on invested capital of 6.0% and a free cash flow yield of 5.8%. On the balance sheet: a debt-to-equity ratio of 2.83 and a current ratio of 0.80. Over the past 52 weeks the share price ranged from $14.09 to $51.68, with a beta of -0.08.
PACS Group, Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 8 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.